Spectrum Pharmaceuticals Inc

JPMORGAN CHASE & CO

Report date

6/30/2023

Quarter

2023 Q2

Filed

8/11/2023

Shares

3,924

Value ($000)

4

Weight

0.0%

2019 Q4 - 2023 Q2 (15 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q2	8/11/2023	4	0.0%	3,924	6/30/2023
2023 Q1	5/18/2023	3	0.0%	3,924	3/31/2023
2022 Q4	2/13/2023	1	0.0%	3,924	12/31/2022
2022 Q3	11/14/2022	5	0.0%	11,745	9/30/2022
2022 Q2	8/11/2022	34	0.0%	43,876	6/30/2022
2022 Q1	5/11/2022	571	0.0%	441,612	3/31/2022
2021 Q4	2/11/2022	624	0.0%	491,656	12/31/2021
2021 Q3	11/12/2021	1,136	0.0%	521,016	9/30/2021
2021 Q2	8/12/2021	2,101	0.0%	560,220	6/30/2021
2021 Q1	5/12/2021	2,042	0.0%	626,527	3/31/2021
2020 Q4	2/19/2021	2,149	0.0%	630,064	12/31/2020
2020 Q3	11/12/2020	3,215	0.0%	769,073	9/30/2020
2020 Q2	8/11/2020	496	0.0%	146,727	6/30/2020
2020 Q1	5/12/2020	341	0.0%	146,827	3/31/2020
2019 Q4	2/11/2020	619	0.0%	169,937	12/31/2019